Structure Therapeutics Inc
(GPCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GPCR | CELC | CRSP | ||
| Company | Structure Therapeutics Inc | Celcuity Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 79.31 | 106.41 | 48.85 | ||
| High | 79.35 | 110.91 | 49.63 | ||
| Low | 72.12 | 103.92 | 45.53 | ||
| Latest | 73.21 | 104.28 | 45.88 | ||
| Change | -8.05 | -3.31 | -4.29 | ||
| % Change | -9.91% | -3.08% | -8.55% | ||
| Volume | 2,149,806 | 892,163 | 2,599,449 | ||
| 20-Day Average Volume | 1,261,765 | 812,688 | 1,814,412 | ||
| Previous Close | 81.26 | 107.59 | 50.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 83.99 | 109.13 | 53.76 | ||
| 20-Day Raw Stochastic | 26.39% | 19.56% | 2.28% | ||
| 20-Day Relative Strength | 49.33 | 49.65 | 37.31 | ||
| Weighted Alpha | +54.04 | +248.22 | -0.72 | ||
| Today's Opinion | 80% Buy | 72% Buy | 56% Sell | ||
| Previous Opinion | 88% Buy | 88% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.00% since 01/29/26 | -6.99% since 01/29/26 | -14.00% since 01/29/26 | ||
| Low | 72.12 on 02/05/26 | 103.92 on 02/05/26 | 45.53 on 02/05/26 | ||
| High | 92.06 on 02/02/26 | 114.50 on 02/03/26 | 53.84 on 01/30/26 | ||
| 1-Month | |||||
| %Chg | +16.63% since 01/05/26 | +0.46% since 01/05/26 | -16.81% since 01/05/26 | ||
| Low | 62.01 on 01/06/26 | 100.38 on 01/12/26 | 45.53 on 02/05/26 | ||
| High | 94.77 on 01/20/26 | 120.32 on 01/27/26 | 60.86 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +127.29% since 11/05/25 | +39.80% since 11/05/25 | -19.49% since 11/05/25 | ||
| Low | 30.94 on 12/04/25 | 72.05 on 11/07/25 | 45.53 on 02/05/26 | ||
| High | 94.90 on 12/08/25 | 120.32 on 01/27/26 | 60.86 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +338.91% since 08/05/25 | +143.42% since 08/05/25 | -17.47% since 08/05/25 | ||
| Low | 15.80 on 08/06/25 | 42.38 on 08/06/25 | 45.53 on 02/05/26 | ||
| High | 94.90 on 12/08/25 | 120.32 on 01/27/26 | 78.48 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,930,695 | 4,978,296 | 4,781,201 | ||
| Shares Outstanding, K | 60,678 | 46,271 | 95,300 | ||
| Annual Sales | 0 | 0 | 37,310,000 | ||
| Annual Net Income | -122,530,000 | -111,780,000 | -366,250,000 | ||
| Last Quarter Sales | 0 | 0 | 890,000 | ||
| Last Quarter Net Income | -65,710,000 | -43,800,000 | -106,440,000 | ||
| 60-Month Beta | -2.06 | 0.36 | 1.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/06/25 | -0.92 on 11/12/25 | -1.17 on 11/10/25 | ||
| Latest Earnings Date | 02/26/26 | 03/30/26 | 02/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||